Rifampin 300 MG capsule 60S
Ended Awarded
- Contract number
- SPE2DB25FW4DQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,337
Award facts
- Contract value 100% obligated
- $3,336.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $3,336.50. This is a firm fixed price delivery order with no set-aside designation, meaning the award was competitively awarded. The ultimate completion date is September 12, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026.
As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. Rifampin, an antibiotic primarily used to treat tuberculosis and other mycobacterial infections, represents the type of essential pharmaceutical commodity that DLA procures to support Defense Health Agency operations and other federal healthcare customers. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains through open competition with the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FW4DQ?
SPE2DB25FW4DQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FW4DQ worth?
The government has obligated $3,337 on SPE2DB25FW4DQ.
Is contract SPE2DB25FW4DQ an order under another contract?
Yes. SPE2DB25FW4DQ is a delivery order under SPE2DB22D2006, an indefinite delivery contract.
Was contract SPE2DB25FW4DQ competed?
The extent of competition for SPE2DB25FW4DQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award